Immunogenicity of a vaccine formulated with the Chlamydia trachomatis serovar F, native major outer membrane protein in a nonhuman primate model

C Cheng, S Pal, I Bettahi, KL Oxford, PA Barry… - Vaccine, 2011 - Elsevier
To determine the ability of a vaccine formulated with the genital Chlamydia trachomatis,
serovar F, native major outer membrane protein (Ct-F-nMOMP), to induce systemic and …
被引用次数：37 相关文章

Immunogenicity of a vaccine formulated with the Chlamydia trachomatis serovar F, native major outer membrane protein in a nonhuman primate model.

C Cheng, S Pal, I Bettahi, KL Oxford, PA Barry… - Vaccine, 2011 - europepmc.org
To determine the ability of a vaccine formulated with the genital Chlamydia trachomatis,
serovar F, native major outer membrane protein (Ct-F-nMOMP), to induce systemic and …
[PDF] academia.edu

[PDF][PDF] Immunogenicity of a vaccine formulated with the Chlamydia trachomatis serovar F, native major outer membrane protein in a nonhuman primate model

C Cheng, S Pal, I Bettahi, KL Oxford, PA Barry… - Vaccine, 2011 - academia.edu
To determine the ability of a vaccine formulated with the genital Chlamydia trachomatis,
serovar F, native major outer membrane protein (Ct-F-nMOMP), to induce systemic and …

Immunogenicity of a vaccine formulated with the Chlamydia trachomatis serovar F, native major outer membrane protein in a nonhuman primate model

C Cheng, S Pal, I Bettahi, KL Oxford, PA Barry… - Vaccine, 2011 - infona.pl
To determine the ability of a vaccine formulated with the genital Chlamydia trachomatis,
serovar F, native major outer membrane protein (Ct-F-nMOMP), to induce systemic and …
[HTML] nih.gov

[HTML][HTML] Immunogenicity of a vaccine formulated with the Chlamydia trachomatis serovar F, native major outer membrane protein in a nonhuman primate model

C Cheng, S Pal, I Bettahi, KL Oxford, PA Barry… - Vaccine, 2011 - ncbi.nlm.nih.gov
To determine the ability of a vaccine formulated with the genital Chlamydia trachomatis,
serovar F, native major outer membrane protein (Ct-F-nMOMP), to induce systemic and …

Immunogenicity of a vaccine formulated with the Chlamydia trachomatis serovar F, native major outer membrane protein in a nonhuman primate model

C Cheng, S Pal, I Bettahi, KL Oxford, PA Barry… - …, 2011 - pubmed.ncbi.nlm.nih.gov
To determine the ability of a vaccine formulated with the genital Chlamydia trachomatis,
serovar F, native major outer membrane protein (Ct-F-nMOMP), to induce systemic and …

[引用][C] Immunogenicity of a vaccine formulated with the Chlamydia trachomatis serovar F, native major outer membrane protein in a nonhuman primate model

C CHENG, S PAL, I BETTAHI, KL OXFORD… - Vaccine, 2011 - pascal-francis.inist.fr
Immunogenicity of a vaccine formulated with the Chlamydia trachomatis serovar F, native major
outer membrane protein in a nonhuman primate model CNRS Inist Pascal-Francis CNRS Pascal …

Immunogenicity of a vaccine formulated with the Chlamydia trachomatis serovar F, native major outer membrane protein in a nonhuman primate model.

CM Cheng, S Pal, I Bettahi, KL Oxford, PA Barry… - 2011 - cabidigitallibrary.org
To determine the ability of a vaccine formulated with the genital Chlamydia trachomatis,
serovar F, native major outer membrane protein (Ct-F-nMOMP), to induce systemic and …

[引用][C] Immunogenicity of a vaccine formulated with the Chlamydia trachomatis serovar F, native major outer membrane protein in a nonhuman primate model

C Cheng, S Pal, I Bettahi, KL Oxford, PA Barry… - 2011

[引用][C] Immunogenicity of a vaccine formulated with the Chlamydia trachomatis serovar F, native major outer membrane protein in a nonhuman primate model

C CHENG, S PAL, I BETTAHI, KL OXFORD, PA BARRY… - Vaccine, 2011 - Elsevier